Pulse Biosciences Inc.

AI Score

XX

Unlock

19.26
1.08 (5.94%)
At close: Apr 24, 2025, 3:59 PM
19.50
1.25%
After-hours: Apr 24, 2025, 07:35 PM EDT
5.94%
Bid 15
Market Cap 1.3B
Revenue (ttm) n/a
Net Income (ttm) -53.59M
EPS (ttm) -0.92
PE Ratio (ttm) -20.93
Forward PE -39.02
Analyst n/a
Ask 25.28
Volume 133,615
Avg. Volume (20D) 189,108
Open 18.63
Previous Close 18.18
Day's Range 18.50 - 19.28
52-Week Range 6.59 - 25.00
Beta 1.88

About PLSE

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed i...

Sector Healthcare
IPO Date May 18, 2016
Employees 75
Stock Exchange NASDAQ
Ticker Symbol PLSE
Full Company Profile
4 weeks ago
+6%
Pulse Biosciences shares are trading higher. The c... Unlock content with Pro Subscription
2 months ago
+14.86%
Pulse Biosciences shares are trading higher after the company announced it appointed a new CFO.